About Us

    mediileap is committed to exploring novel solutions to the world's most challenging health problems. Our mission is to push the boundaries and leverage scientific discovery to positively impact the lives of Canadians and people across the globe. We believe in applying science for a better, healthier world.


    The mediileap team has received early funding support from The National Research Council of Canada Industrial Research Assistance Program (IRAP); The Natural Sciences and Engineering Research Council of Canada; NSERC, and Mitacs Accelerate. This financial support as enabled our team to move quickly towards the development of a viable diagnostic solution to help fight COVID-19.

Saliva Based Rapid Test for COVID-19

The mediileap team is working towards the development of a single-use rapid Saliva based SARS-CoV-2 testing kit that can be used in non-clinical environments such Point of Care (POC) and home. Our team is working in collaboration with renowned Health Researchers at McMaster University in Ontario. We believe our work jointly presents an important opportunity to manage contagion spread while alleviating pressure on strained healthcare systems in Canada and around the world.

The rapid spread of COVID-19 has made the need for reliable and affordable testing more important than ever. Existing testing methods remain largely invasive and unavailable outside of hospital or clinical settings. Accurate diagnosis is further restricted by the ongoing shortages of the tools needed to perform tests, i.e. swabs, reagents, lab space, etc. This pandemic has resulted not only in drastic, though necessary measures such as school and workplace closures. The economic impact of these measures has been drastic with mounting job losses, business closures.

Contact Us

Find Out More About Our Test. health@mediileap.com or fill out the form, below.

Please enter your name.

Please enter your email address.

Please enter a longer message.

Thank you for your inquiry! We will get back to you within 48 hours.

Investor Details. investors@mediileap.com

Everyday. Everyone. Everywhere.